Denteric is developing therapies to treat Porphyromonas gingivalis related diseases. Our initial focus is on severe periodontal disease. Our vaccine therapy aims to generate antibodies that neutralise the proteolytic toxins of the bacteria that cause periodontal disease and inflammation. We are c... Read more
This company has no teams yet
This company has no offices yet